Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

Buzz on the Bullboards: AI stocks and energy plays getting noticed

Markets have had it rough, starting the month of August lower following one downer of a corporate earnings report after another. Wall Street has struggled since credit assessor Fitch downgraded the United States’ credit rating from gold-standard AAA to...
Jonathon Brown | August 3, 2023 |

Buzz on the Bullboards: Which stocks are turning inertia into momentum?

Markets have stumbled this week, especially tech indices as rising bond yields in the U.S. have had their way with the sector, which is sensitive to higher interest rates. One of the big updates of late, Datametrex AI Ltd. (TSXV:DM) brought investors up to spe...
Jonathon Brown | March 30, 2023 |

Covid-19: Who, what, when, where and why

If there is one thing we know about the coronavirus, it’s that getting a jump on it helps to limit the number of infections. Clearly the best time to stop this, and all outbreaks, is in its early stages. Both China and the United States have been accused of...
Richard (Rick) Mills | April 13, 2020 |

Novavax Announces Its First-in-Human Coronavirus Vaccine Trial Will Begin in Mid-May

Shares of Novavax traded 20% higher setting a new 52-week high price after the company reported that it has accelerated initiation of a Phase 1 clinical trial for its coronavirus vaccine candidate NVX-CoV2373. The study will commence in mid-May with preliminary results expec...
Streetwise Reports | April 9, 2020 |

Resurgent dollar paving route to higher gold

In the 1960s, French politician Valéry d'Estaing complained that the United States enjoyed an “exorbitant privilege” due to the dollar’s status as the world’s reserve currency. He had a point. Because the dollar is the ...
Richard (Rick) Mills | March 24, 2020 |

A psychedelic renaissance

Fifty-three years after LSD was banned by the FDA, psychedelic drugs are making a comeback. Only instead of being the pills, mushrooms and acid tabs that helped college students to “turn on, tune in, drop out” Timothy Leary-style, today’...
Richard (Rick) Mills | December 3, 2019 |

As Drone Market Changes, This Small Cap Offers Opportunities

In my first write up about drones, I used the phrase "The Drones are coming." Perhaps now it is more appropriate "The Drones are multiplying like rabbits." The FAA announced that there were more than 122,000 commercial drone pilots in early 2018. Combined with the 87...
Streetwise Reports | November 27, 2019 |

Reliq Re-establishes Itself as Community Care Technology Leader ...

Reliq Re-establishes Itself as Community Care Technology Leader Amidst Sweeping Federal Medicare/Medicaid Changes A shift in the industry leads to big new contracts and parabolic stock performance for this small cap. A sweeping new development in what federal...
Streetwise Reports | November 14, 2019 |

Iovance Biotherapeutics Shares Rise 12% on Updated Phase 2 Melanoma Study Results

Shares of Iovance Biotherapeutics traded 12% higher today after the firm reported updated clinical data from its phase 2 lifileucel metastatic melanoma trial. Just a few days after reporting third quarter 2019 earnings, late-stage biotechnology company Iovance Biothe...
Streetwise Reports | November 12, 2019 |

The Power of Scarcity

The fast food world gave us an interesting case study in supply and demand last week. By now you’ve no doubt heard about The Chicken Sandwich, the surprise superstar menu item from Popeyes Louisiana Kitchen that’s launched 1,000 blog post...
Frank Holmes | September 3, 2019 |
1 2